Comprehensive Side Effects, Safety Risks, and Medical Contraindications for GLP-1 Therapy All GLP-1 medications, whether FDA-approved branded products or compounded formulations prepared by licensed pharmacies registered with FDA as facilities, carry potential risks requiring careful consideration and ongoing medical monitoring
Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: Reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse J Pharmacol Sci, 95 (1) (2004), pp
This contrasts with the experience of nausea, which although still manageable, was the more common reason for dose interruptions or early withdrawal
PubMed Central , doi:10.1186/1743-7075-4-24
C S 3 S 48 NGUYN VN TRI PHNG LIT THANH XUN H NI 9
doi:10.1056/NEJMoa1607141 While these studies may not directly address the effects of semaglutide on menstruation, they provide insights into the metabolic and hormonal effects of GLP-1 receptor agonists, which could potentially influence menstrual patterns
